(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP...
Stats | |
---|---|
Today's Volume | 42 066.00 |
Average Volume | 100 880 |
Market Cap | 30.29B |
EPS | INR0 ( 2024-01-23 ) |
Next earnings date | ( INR2.80 ) 2024-05-21 |
Last Dividend | INR2.25 ( 2023-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 29.82 |
ATR14 | INR0.319 (0.10%) |
Volume Correlation
Indoco Remedies Limited Correlation
10 Most Positive Correlations | |
---|---|
ICICIGI.NS | 0.898 |
RADIOCITY.NS | 0.889 |
INSECTICID.NS | 0.883 |
INDUSTOWER.NS | 0.881 |
HDFCAMC.NS | 0.878 |
SAREGAMA.NS | 0.876 |
IDEA.NS | 0.874 |
PUNJABCHEM.NS | 0.869 |
SHOPERSTOP.NS | 0.866 |
TCIFINANCE.NS | 0.865 |
10 Most Negative Correlations | |
---|---|
SICAGEN.NS | -0.883 |
SMLT.NS | -0.881 |
OIL.NS | -0.875 |
STAMPEDE.NS | -0.873 |
STERTOOLS.NS | -0.871 |
NEWGEN.NS | -0.871 |
KEERTI.NS | -0.869 |
SURYAROSNI.NS | -0.863 |
ROTO.NS | -0.862 |
PDSMFL.NS | -0.856 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Indoco Remedies Limited Correlation - Currency/Commodity
Indoco Remedies Limited Financials
Annual | 2022 |
Revenue: | INR16.40B |
Gross Profit: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
Revenue: | INR16.40B |
Gross Profit: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
Revenue: | INR15.04B |
Gross Profit: | INR10.40B (69.16 %) |
EPS: | INR16.80 |
FY | 2021 |
Revenue: | INR12.19B |
Gross Profit: | INR8.59B (70.49 %) |
EPS: | INR10.10 |
Financial Reports:
No articles found.
Indoco Remedies Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0.750 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR2.25 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.667 | 2005-09-15 |
Last Dividend | INR2.25 | 2023-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | INR20.23 | -- |
Avg. Dividend % Per Year | 0.26% | -- |
Score | 1.79 | -- |
Div. Sustainability Score | 2.93 | |
Div.Growth Potential Score | 3.59 | |
Div. Directional Score | 3.26 | -- |
Year | Amount | Yield |
---|---|---|
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.000 | 0.52% |
2019 | INR0.300 | 0.14% |
2020 | INR0.300 | 0.16% |
2021 | INR1.500 | 0.49% |
2022 | INR0.750 | 0.17% |
2023 | INR2.25 | 0.55% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RUPA.NS | Dividend Junior | 2023-08-01 | Annually | 13 | 0.60% | |
LODHA.NS | Dividend Junior | 2023-09-07 | Insufficient data to determine frequency | 2 | 0.06% | |
GENCON.NS | Dividend Junior | 2023-09-22 | Annually | 4 | 0.08% | |
ARROWGREEN.NS | Dividend Junior | 2023-09-20 | Annually | 10 | 0.15% | |
TFCILTD.NS | Dividend Junior | 2023-08-11 | Annually | 23 | 1.38% | |
ORIENTBELL.NS | No Dividend Player | 2023-07-18 | Annually | 18 | 0.14% | |
IRCON.NS | Dividend Knight | 2023-09-05 | Semi-Annually | 6 | 3.39% | |
CROMPTON.NS | Dividend Junior | 2023-07-06 | Annually | 8 | 0.52% | |
SHIVALIK.NS | Dividend Junior | 2023-09-22 | Annually | 3 | 0.03% | |
MANORAMA.NS | Dividend Junior | 2023-09-11 | Insufficient data to determine frequency | 2 | 0.07% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0571 | 1.500 | 8.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0969 | 1.500 | -0.0350 | -0.0524 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 5.33 | 1.000 | 9.14 | 9.14 | [3 - 30] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 2.84 | 5.68 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.691 | 1.000 | 1.820 | 1.820 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.104 | 1.000 | 9.92 | 9.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 29.81 | 1.000 | 7.09 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0969 | 2.50 | -0.0225 | -0.0524 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 5.68 | [0 - 30] |
dividendYielPercentageTTM | 0.685 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.449 | 1.500 | -0.338 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0742 | 1.000 | -0.645 | 0 | [0.1 - 0.5] |
Total Score | 3.59 |
Indoco Remedies Limited
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators